GO:0048291 isotype switching to IgG isotypes: B Cell Class Switching, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0048291 describes the biological process by which activated B cells switch from producing IgM to producing IgG isotypes through intrachromosomal recombination between switch regions in the immunoglobulin heavy chain locus.
• This process is essential for generating antibody diversity and tailoring immune responses to different pathogens, and it is conserved across vertebrates.
• Key molecular drivers include CD40/CD40L signaling, cytokines such as IL-21 and IL-4, and metabolic regulators like MCT1 that influence histone acetylation at switch regions.
• Dysregulated IgG isotype switching is associated with autoimmune diseases, chronic infections, and cancer, making it a target for therapeutic intervention.
• Recent studies show that sequential class switching can generate antigen-specific gut IgA from IgG1 B cells, highlighting the plasticity of the process.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) are powerful tools to dissect the genetic and epigenetic regulation of IgG isotype switching.
Description
Isotype switching to IgG isotypes (GO:0048291) is a fundamental process in adaptive immunity whereby activated B cells change the constant region of the immunoglobulin heavy chain from IgM to an IgG subclass, enabling specialized effector functions. This recombination event occurs between switch regions located 5' of the IgM and IgG constant region genes, resulting in a deleted intervening sequence and a new antibody isotype with distinct biological properties. Understanding this process is critical for vaccine development, autoimmunity research, and cancer immunotherapy, as IgG antibodies play central roles in pathogen neutralization, opsonization, and immune complex formation. Recent advances have identified metabolic and epigenetic regulators, such as MCT1-governed pyruvate metabolism and H3K27 acetylation, that control class-switch recombination, opening new avenues for therapeutic modulation. Moreover, sequential switching from IgG1 to IgA in the gut highlights the dynamic nature of isotype transitions and their importance in mucosal immunity. This article provides a comprehensive overview of the mechanisms, genes, and research methods associated with GO:0048291, based on authoritative QuickGO data and verified PubMed literature.
isotype switching to IgG isotypes At A Glance
| GO ID | GO:0048291 |
|---|---|
| GO term | isotype switching to IgG isotypes |
| Ontology | biological_process |
| Synonym | class switching to IgG isotypes; isotype switch recombination to IgG isotypes |
| Definition | The switching of activated B cells from IgM biosynthesis to biosynthesis of an IgG isotype, accomplished through a recombination process involving an intrachromosomal deletion between switch regions that reside 5' of the IgM and one of the IgG constant region gene segments in the immunoglobulin heavy chain locus. |
| Major function | Generation of IgG antibodies with specialized effector functions |
| Related processes | Class-switch recombination, somatic hypermutation, B cell activation |
| Key regulators | CD40/CD40L, IL-21, IL-4, AID, MCT1 |
| Disease relevance | Autoimmunity, immunodeficiency, cancer, chronic infections |
What Is GO:0048291?
GO:0048291, isotype switching to IgG isotypes, is defined as the switching of activated B cells from IgM biosynthesis to biosynthesis of an IgG isotype, accomplished through a recombination process involving an intrachromosomal deletion between switch regions that reside 5' of the IgM and one of the IgG constant region gene segments in the immunoglobulin heavy chain locus. This process is a type of class-switch recombination that specifically targets IgG subclasses (IgG1, IgG2, IgG3, IgG4 in humans) and is driven by activation-induced cytidine deaminase (AID) and other factors.
Why Is isotype switching to IgG isotypes Important in Cell Biology?
Isotype switching to IgG isotypes is crucial for effective humoral immunity because IgG antibodies are the most abundant immunoglobulins in serum and mediate key functions such as neutralization, opsonization, and complement activation. Defects in this process lead to hyper-IgM syndromes and increased susceptibility to infections, while aberrant IgG switching contributes to autoimmune diseases and cancer progression. Understanding the regulation of GO:0048291 is therefore essential for developing vaccines, immunotherapies, and treatments for antibody-mediated disorders.
• Enables production of IgG antibodies that are critical for long-term protective immunity after infection or vaccination.
• Defects in IgG isotype switching cause hyper-IgM syndrome, characterized by recurrent infections.
• IL-21 and IL-4 differentially regulate human naive B cell switching to IgG and IgA, influencing vaccine responses.
• MCT1-governed pyruvate metabolism and H3K27 acetylation are essential for class-switch recombination, linking metabolism to epigenetic control.
• Sequential class switching from IgG1 to IgA in the gut demonstrates plasticity and mucosal immune regulation.
• T-follicular-like CD8+ T cell responses in chronic HIV infection are associated with antibody isotype switching to IgG.
• Isotype switching converts anti-CD40 antagonism to agonism, eliciting potent antitumor activity.
• Intranasal booster drives class switching and homing of memory B cells for mucosal IgA responses.
• Dysregulated IgG switching is implicated in autoimmune diseases such as lupus and rheumatoid arthritis.
• CRISPR screening can identify novel regulators of IgG isotype switching for therapeutic targeting.
What Happens During isotype switching to IgG isotypes?
B Cell Activation and Cytokine Signals
In simple terms: B cells need to be activated by signals from T cells and cytokines to start switching.
Activated B cells receive signals through CD40 engagement by CD40 ligand (CD40L) on T cells, which is essential for class-switch recombination. Cytokines such as IL-21 and IL-4 further direct the switching process; IL-21 induces switching to IgG and IgA in human naive B cells, and this is differentially regulated by IL-4. In chronic HIV infection, T-follicular-like CD8+ T cell responses are associated with antibody isotype switching to IgG, indicating a role for T cell help.
Transcriptional Activation of Switch Regions
In simple terms: The DNA regions that will be cut are first transcribed to open up the chromatin.
Upon activation, germline transcription of the switch (S) regions upstream of the IgM and IgG constant genes occurs, producing non-coding RNA that facilitates accessibility for recombination. This transcription is regulated by promoters and enhancers responsive to cytokines and transcription factors such as NF-kB and STAT6.
AID-Mediated DNA Deamination and Double-Strand Breaks
In simple terms: An enzyme called AID chemically modifies DNA bases, leading to breaks that are repaired by recombination.
Activation-induced cytidine deaminase (AID) deaminates cytosine to uracil in single-stranded DNA of the switch regions, creating U:G mismatches that are processed by base excision repair and mismatch repair pathways to generate double-strand breaks. These breaks are required for the subsequent recombination between Sμ and Sγ regions.
Recombination and Deletion of Intervening DNA
In simple terms: The broken ends are joined together, and the DNA in between is deleted, bringing the IgG gene next to the promoter.
The double-strand breaks in Sμ and Sγ regions are repaired by non-homologous end joining, resulting in an intrachromosomal deletion that removes the intervening DNA and places the IgG constant region gene downstream of the VDJ exon. This recombination is mediated by factors such as 53BP1 and ATM, and is influenced by epigenetic modifications including H3K27 acetylation, which is regulated by MCT1-governed pyruvate metabolism.
Expression of IgG Antibodies
In simple terms: The B cell now produces IgG instead of IgM, which has different functions.
Following recombination, the B cell transcribes the rearranged heavy chain gene, producing IgG antibodies with the same antigen specificity but new effector functions. These IgG antibodies can undergo further sequential switching to IgA in mucosal tissues, as shown by the generation of antigen-specific gut IgA from IgG1 B cells. Intranasal booster immunization drives class switching and homing of memory B cells for mucosal IgA responses, highlighting the dynamic nature of isotype transitions.
Key Genes Involved in GO:0048291 isotype switching to IgG isotypes
The following genes and proteins are central to the regulation and execution of isotype switching to IgG isotypes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CD40LG | CD40 ligand; binds CD40 on B cells to induce class switching | Defects cause hyper-IgM syndrome; target for immunotherapy |
| CD40 | Receptor on B cells; mediates T cell-dependent activation | Mutations lead to immunodeficiency; anti-CD40 antibodies can modulate switching |
| AICDA | Activation-induced cytidine deaminase; initiates DNA breaks in switch regions | Essential for class-switch recombination; mutations cause hyper-IgM syndrome |
| IL21 | Cytokine that induces IgG and IgA switching in human naive B cells | Differentially regulated by IL-4; vaccine adjuvant target |
| IL4 | Cytokine that modulates IL-21-induced switching | Influences IgG subclass selection; allergy and asthma research |
| SLC16A1 | MCT1; monocarboxylate transporter 1; regulates pyruvate metabolism and H3K27 acetylation | Knockout impairs class-switch recombination; metabolic target |
| IGHM | IgM constant region gene; donor switch region for recombination | Targeted in class-switch recombination studies |
| IGHG1 | IgG1 constant region gene; acceptor switch region | Polymorphisms affect IgG subclass levels and disease susceptibility |
| IGHG2 | IgG2 constant region gene | Associated with responses to polysaccharide vaccines |
| IGHG3 | IgG3 constant region gene | Linked to autoimmune diseases and infection outcomes |
| IGHG4 | IgG4 constant region gene | Related to IgG4-related disease and tolerance |
| NFKB1 | Transcription factor regulating germline transcription of switch regions | Involved in B cell activation and class switching |
| STAT6 | Transcription factor mediating IL-4 signaling | Regulates IgG subclass switching |
| TP53BP1 | 53BP1; DNA repair factor involved in class-switch recombination | Defects impair switching and cause immunodeficiency |
| ATM | Ataxia telangiectasia mutated; DNA damage response kinase | Mutations lead to impaired class switching and immunodeficiency |
| CD8A | CD8+ T cell marker; T-follicular-like responses associated with IgG switching | HIV infection and vaccine research |
| MST1 | Macrophage stimulating 1; not directly linked but included for context | No direct evidence; placeholder for potential regulators |
How Is isotype switching to IgG isotypes Regulated?
Isotype switching to IgG isotypes is tightly regulated at multiple levels. Cytokine signals, particularly IL-21 and IL-4, control the choice of IgG subclass by inducing specific germline transcription. CD40/CD40L interaction provides a critical co-stimulatory signal, and deficiency in this pathway leads to hyper-IgM syndrome with impaired IgG switching. Metabolic regulation through MCT1-governed pyruvate metabolism influences H3K27 acetylation at switch regions, thereby modulating recombination. Additionally, DNA repair pathways involving 53BP1 and ATM are essential for resolving double-strand breaks during switching. Recent evidence indicates that sequential switching can occur, with IgG1 B cells switching to IgA in the gut, suggesting additional layers of regulation by mucosal factors.
isotype switching to IgG isotypes and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CD40LG | Hyper-IgM syndrome | CD40LG knockout mice; patient-derived B cells |
| AICDA | Hyper-IgM syndrome type 2 | AICDA knockout mice; CRISPR knockout in B cell lines |
| SLC16A1 | Metabolic regulation of class switching | MCT1 knockout mice; conditional knockout in B cells |
| IL21 | Autoimmunity and vaccine responses | IL21 receptor knockout mice; human B cell cultures |
| CD40 | Cancer immunotherapy | Anti-CD40 agonist antibodies; CD40 knock-in models |
Hyper-IgM Syndrome
Defects in CD40L/CD40 signaling or AID cause hyper-IgM syndrome, characterized by normal or elevated IgM but absent or low IgG, IgA, and IgE, leading to recurrent infections. This highlights the essential role of GO:0048291 in protective immunity.
Autoimmune Diseases
Aberrant IgG isotype switching contributes to autoimmunity, as IgG autoantibodies mediate tissue damage in diseases such as systemic lupus erythematosus and rheumatoid arthritis. Understanding the regulation of IgG switching may provide therapeutic targets.
Cancer Immunotherapy
Isotype switching can convert anti-CD40 antagonism to agonism, eliciting potent antitumor activity, suggesting that modulating IgG switching can enhance cancer immunotherapy. Additionally, T-follicular-like CD8+ T cell responses in chronic HIV infection are associated with IgG switching, which may influence viral control.
Mucosal Immunity and Vaccines
Sequential class switching from IgG1 to IgA in the gut is important for mucosal immunity, and intranasal boosters can drive class switching and homing of memory B cells for mucosal IgA responses. This has implications for vaccine design against mucosal pathogens.
From isotype switching to IgG isotypes-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate IgG isotype switching? | Knockout mouse or CRISPR knockout in B cell lines |
| Does a point mutation in AICDA affect switching efficiency? | Point-mutation knock-in mice or cell lines |
| Can a tagged version of AID track switch region localization? | Knock-in of fluorescent tag at AICDA locus |
| Does overexpression of IL-21 enhance IgG switching? | Retroviral overexpression in primary B cells |
| What is the role of MCT1 in class switching? | Conditional knockout of SLC16A1 in B cells |
| Can CRISPR screening identify novel regulators of IgG switching? | Genome-wide CRISPR library screening in B cell lines |
How to Study the isotype switching to IgG isotypes Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Flow cytometry | Surface IgG/IgM expression | Quantify switching efficiency in B cell cultures |
| ELISA | Secreted IgG levels | Measure antibody production after stimulation |
| RNA-seq | Germline transcripts and IgG mRNA | Transcriptional profiling of switch regions |
| ChIP-seq | Histone modifications (e.g., H3K27ac) | Epigenetic regulation of switch regions |
| ATAC-seq | Chromatin accessibility | Identify open regions during switching |
| CRISPR screen | Gene essentiality for switching | Discover novel regulators |
| Immunofluorescence | AID localization and switch region foci | Visualize recombination events |
| Western blot | Protein expression of AID, MCT1, etc. | Validate knockout or overexpression |
Flow Cytometry and ELISA
Flow cytometry using antibodies against surface IgG and IgM can quantify isotype switching at the single-cell level, while ELISA measures secreted IgG in culture supernatants. These methods are standard for assessing switching efficiency in vitro.
RNA Sequencing and Germline Transcript Analysis
RNA-seq can detect germline transcripts of switch regions and quantify IgG heavy chain mRNA, providing insights into transcriptional regulation. This is useful for identifying cytokine-induced changes.
Chromatin Immunoprecipitation (ChIP) and ATAC-seq
ChIP for histone modifications such as H3K27 acetylation and ATAC-seq for chromatin accessibility can reveal epigenetic changes at switch regions during IgG switching. These methods help dissect the role of metabolic regulators.
CRISPR Screening and Functional Genomics
Genome-wide CRISPR knockout or activation screens in B cell lines can identify novel genes that regulate IgG isotype switching. This approach is powerful for discovering therapeutic targets.
How CRISPR Can Be Used to Study GO:0048291 isotype switching to IgG isotypes
Knockout
CRISPR knockout of candidate genes such as SLC16A1 (MCT1) in B cell lines or primary B cells can determine their requirement for IgG isotype switching. For example, MCT1 knockout impairs class-switch recombination by reducing H3K27 acetylation at switch regions. Similarly, AICDA knockout abolishes switching, serving as a positive control.
Point Mutation
Introducing point mutations in genes like AICDA or CD40 can model human immunodeficiency syndromes and dissect catalytic versus non-catalytic functions. For instance, mutations in AID's catalytic domain affect deamination activity and switching efficiency.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) at the AICDA locus allows real-time tracking of AID expression and localization during switching. Knock-in of human IgG constant regions into mouse models can humanize antibody responses for therapeutic testing.
Overexpression
Overexpression of cytokines such as IL-21 or transcription factors like STAT6 in B cells can enhance IgG switching and help identify downstream targets. This approach is useful for studying gain-of-function effects.
How EDITGENE Supports isotype switching to IgG isotypes Research
Researchers studying isotype switching to IgG isotypes-related genes often need to determine whether a candidate gene is causally involved in the process or merely correlated. EDITGENE provides comprehensive CRISPR-based services to enable precise genetic manipulation and functional validation.
Contact EDITGENE today to design your custom CRISPR model for isotype switching to IgG isotypes research.
Frequently Asked Questions About isotype switching to IgG isotypes
What is isotype switching to IgG isotypes?
Isotype switching to IgG isotypes (GO:0048291) is the process by which activated B cells change from producing IgM to producing IgG antibodies through a DNA recombination event in the immunoglobulin heavy chain locus.
What genes are involved in isotype switching to IgG isotypes?
Key genes include CD40LG, CD40, AICDA, IL21, IL4, SLC16A1 (MCT1), and the immunoglobulin heavy chain constant region genes (IGHM, IGHG1-4).
How is isotype switching to IgG isotypes regulated?
It is regulated by CD40/CD40L signaling, cytokines such as IL-21 and IL-4, metabolic factors like MCT1, and epigenetic modifications including H3K27 acetylation.
What diseases are associated with defective IgG isotype switching?
Defects cause hyper-IgM syndrome, while dysregulated switching is linked to autoimmune diseases and cancer.
What methods are used to study IgG isotype switching?
Common methods include flow cytometry, ELISA, RNA-seq, ChIP-seq, ATAC-seq, and CRISPR screens.
Can CRISPR be used to study isotype switching to IgG isotypes?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect the genetic regulation of IgG switching.
What is the role of MCT1 in IgG isotype switching?
MCT1 (SLC16A1) governs pyruvate metabolism, which is essential for class-switch recombination through H3K27 acetylation at switch regions.
How does IL-21 affect IgG switching?
IL-21 induces isotype switching to IgG and IgA in human naive B cells, and this effect is differentially regulated by IL-4.
What is the difference between IgM and IgG antibodies?
IgM is the first antibody produced during an immune response, while IgG is produced after class switching and mediates long-term immunity, opsonization, and neutralization.
Can IgG isotype switching be targeted therapeutically?
Yes, modulating IgG switching is being explored in cancer immunotherapy and vaccine development, e.g., anti-CD40 antibodies that convert antagonism to agonism.
Conclusion
Isotype switching to IgG isotypes (GO:0048291) is a cornerstone of adaptive immunity, enabling B cells to produce antibodies with specialized effector functions. Its regulation involves a complex interplay of cytokines, transcription factors, metabolic pathways, and epigenetic modifications, with defects leading to immunodeficiency and dysregulation contributing to autoimmunity and cancer. Advances in CRISPR-based models and functional genomics are accelerating the discovery of novel regulators and therapeutic targets. EDITGENE's comprehensive services support researchers in dissecting this process with precision and scale.
References
- 1. Chi W et al.. 2024. MCT1-governed pyruvate metabolism is essential for antibody class-switch recombination through H3K27 acetylation.. Nat Commun 15(1):163 PMID: 38167945
- 2. Siniscalco ER et al.. 2025. Sequential class switching generates antigen-specific gut IgA from IgG1 B cells.. Immunity 58(12):3075-3093.e6 PMID: 41253159
- 3. Castigli E et al.. 1995. CD40 ligand/CD40 deficiency.. Int Arch Allergy Immunol 107(1-3):37-9 PMID: 7542090
- 4. Senger K et al.. 2015. Antibody Isotype Switching in Vertebrates.. Results Probl Cell Differ 57:295-324 PMID: 26537387
- 5. Avery DT et al.. 2008. IL-21-induced isotype switching to IgG and IgA by human naive B cells is differentially regulated by IL-4.. J Immunol 181(3):1767-79 PMID: 18641314
- 6. Romero-Martín L et al.. 2022. T-Follicular-Like CD8(+) T Cell Responses in Chronic HIV Infection Are Associated With Virus Control and Antibody Isotype Switching to IgG.. Front Immunol 13:928039 PMID: 35784304
- 7. Yu X et al.. 2020. Isotype Switching Converts Anti-CD40 Antagonism to Agonism to Elicit Potent Antitumor Activity.. Cancer Cell 37(6):850-866.e7 PMID: 32442402
- 8. Chen S et al.. 2026. Intranasal booster drives class switching and homing of memory B cells for mucosal IgA response.. JCI Insight 11(3) PMID: 41433108
